Initial PrEP product choice: results from the HPTN 084 open-label extension

被引:0
|
作者
Delany-Moretlwe, S. [1 ]
Hanscom, B. [2 ]
Angira, F. [3 ]
Dadabhai, S. [4 ]
Gadama, D. [5 ]
Mirembe, B. [6 ]
Bhondai, M.
Innes, S. [8 ]
Kalonji, D. [9 ]
Makhema, J. [10 ]
Mandima, P. [7 ]
Marais, A. [11 ]
Mpendo, J. [12 ]
Mukwekwerere, P. [7 ]
Mgodi, N.
Naidoo, V. [13 ]
Ntege, P. Nahirya [14 ]
Nuwagaba-Biribonwoha, H. [15 ]
Roos, E. [1 ]
Singh, N. [16 ]
Siziba, B. [7 ]
Spooner, E.
Farrior, J. [17 ]
Rose, S. [17 ]
Piwowar-Manning, E. [18 ]
Burton, M. [19 ]
Soto-Torres, L. [20 ]
Rooney, J. [21 ]
Rinehart, A. [22 ]
Cohen, M.
Hosseinipour, M. [23 ,24 ]
机构
[1] Univ Witwatersrand, Wits RHI, Johannesburg, South Africa
[2] Fred Hutchinson Canc Res Inst, Stat Ctr HIV AIDS Res Prevent, Seattle, WA USA
[3] KEMRI, Kisumu, Kenya
[4] Coll Med Blanytre, Blantyre, Malawi
[5] UNC Project Malawi, Lilongwe, Malawi
[6] Johns Hopkins Univ Res Collaborat, Makerere Univ, Kampala, Uganda
[7] Univ Zimbabwe, Clin Trials Res Ctr, Harare, Zimbabwe
[8] Desmond Tutu Hlth Fdn, Cape Town, South Africa
[9] South African Med Res Council, HIV & Other Infect Dis Res Unit, Durban, South Africa
[10] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana
[11] Univ Witwatersrand, Perinatal HIV Res Unit, Soweto, South Africa
[12] UVRI IAVI, Entebbe, Uganda
[13] Univ Stellenbosch, Desmond Tutu TB Ctr, Stellenbosch, South Africa
[14] Baylor Coll Med, Childrens Fdn Uganda, Kampala, Uganda
[15] Columbia Univ, Mailman Sch Publ Hlth, Eswatini Prevent Ctr, Mbabane, South Africa
[16] South African Med Res Council, Durban, South Africa
[17] FHI360, Durham, NC USA
[18] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[19] Fred Hutchinson Canc Res Inst, Seattle, WA USA
[20] NIAID, Rockville, MD USA
[21] Gilead Sci, Foster City, CA USA
[22] ViiV Healthcare, Durham, NC USA
[23] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[24] UNC Project Malawi, Lilongwe, Malawi
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
OALBX0203
引用
收藏
页数:2
相关论文
共 50 条
  • [1] The Effect of Disclosure of PrEP Use on Adherence Among African Young Women in an Open-Label PrEP Study: Findings from HPTN 082
    Geetha Beauchamp
    Sybil Hosek
    Deborah Donnell
    Kwun C. G. Chan
    Peter L. Anderson
    Bonnie J. Dye
    Nyaradzo Mgodi
    Linda-Gail Bekker
    Sinead Delany-Moretlwe
    Connie Celum
    AIDS and Behavior, 2024, 28 : 1512 - 1521
  • [2] The Effect of Disclosure of PrEP Use on Adherence Among African Young Women in an Open-Label PrEP Study: Findings from HPTN 082
    Beauchamp, Geetha
    Hosek, Sybil
    Donnell, Deborah
    Chan, Kwun C. G.
    Anderson, Peter L.
    Dye, Bonnie J.
    Mgodi, Nyaradzo
    Bekker, Linda-Gail
    Delany-Moretlwe, Sinead
    Celum, Connie
    AIDS AND BEHAVIOR, 2024, 28 (05) : 1512 - 1521
  • [3] Results from an open-label extension study of etanercept in ankylosing spondylitis
    Davis, J
    Webb, A
    Lund, S
    Sack, K
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (02): : 302 - 304
  • [4] Characteristics and oral PrEP adherence in the TDF2 open-label extension in Botswana
    Henderson, Faith
    Taylor, Allan
    Chirwa, Lovemore
    Williams, Tiffany
    Borkowf, Craig
    Kasonde, Michael
    Mutanhaurwa, Rodreck
    Matlhaba, Onkabetse
    Hageman, Kathy
    Casillas, Paula
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2015, 18
  • [5] DONIDALORSEN FOR HEREDITARY ANGIOEDEMA: RESULTS FROM THE OASISPLUS OPEN-LABEL EXTENSION STUDY
    Tachdjian, R.
    Riedl, M.
    Bordone, L.
    Newman, K.
    Treadwell, S.
    Lin, T.
    Yarlas, A.
    Cohn, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S38 - S38
  • [6] Trofinetide for the treatment of Rett syndrome: Results from the open-label extension LILAC study
    Percy, Alan K.
    Neul, Jeffrey L.
    Benke, Timothy A.
    Berry-Kravis, Elizabeth M.
    Glaze, Daniel G.
    Marsh, Eric D.
    An, Di
    Bishop, Kathie M.
    Youakim, James M.
    MED, 2024, 5 (09): : 1178 - 1189.e3
  • [7] Olanzapine efficacy and tolerability in adolescents with schizophrenia: Results from an open-label extension phase
    Robertson-Plouch, Carol
    Kryzhanovskaya, Ludmila
    Schulz, Charles
    McDougle, Christopher J.
    Frazier, Jean A.
    Xu, Wen
    Carlson, Janice
    Tohen, Mauricio
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S215 - S216
  • [8] Olanzapine efficacy and tolerability in adolescents with schizophrenia: results from an open-label extension phase
    Robertson-Plouch, Carol
    Kryzhanovskaya, Ludmila
    Schulz, Charles
    McDougle, Christopher
    Frazier, Jean
    Xu, Wen
    Carlson, Janice
    Tohen, Mauricio
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (06) : 879 - 879
  • [9] Open-label extension studies and misinformation
    Schneider, Lon S.
    ARCHIVES OF NEUROLOGY, 2006, 63 (07) : 1036 - 1036
  • [10] What are open-label extension studies for?
    Taylor, WJ
    Weatherall, M
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (04) : 642 - 643